A New Era in HIV Prevention with Long-Acting Injections
Zimbabwe has started rolling out Lenacapavir, the new long-acting injectable HIV-prevention drug, becoming one of the first countries…
Prevalence and determinants of chronic kidney disease among HIV/AIDS patients in selected governmental hospitals at Addis Ababa, Ethiopia: a retrospective cross-sectional study | BMC Infectious Diseases
Murata K, Baumann NA, Saenger AK, Larson TS, Rule AD, Lieske JC. Relative performance of the MDRD and…
Global Virus Network announces the addition of three new Centers of Excellence
The Global Virus Network (GVN), a coalition of leading medical virologists representing 80+ Centers of Excellence and Affiliates…
HIV/AIDS research has saved millions of lives globally and led to innovative advances in multiple diseases
SEATTLE – October 27, 2025 –Leaders in HIV research highlighted the critical role of that research has played…
China’s hi-tech push, Aids and poverty fights in focus as vice-premiers tour provinces
High technology and low incomes were in sharp focus in China late last week as two of its…
Highly targeted gene therapy could revolutionize treatment for cancers linked to herpesvirus
In a preclinical study, UC Davis Comprehensive Cancer Center scientists developed a highly targeted gene therapy that could…